(Q42634097)
Statements
Safety and efficacy of long-acting risperidone in schizophrenia: a 12-week, multicenter, open-label study in stable patients switched from typical and atypical oral antipsychotics (English)
Jean-Pierre Lindenmayer
Els Eerdekens
Sally A Berry
Mariëlle Eerdekens